Literature DB >> 2553187

Effects of OPC-88117, a new antiarrhythmic agent, on the electrophysiological properties of rabbit isolated hearts.

Y Nezasa1, I Kodama, J Toyama.   

Abstract

1. Effects of a new antiarrhythmic agent, OPC-88117, on the conduction properties and excitability of Langendorff-perfused rabbit hearts were compared with those of lignocaine. 2. OPC-88117 above 10(-5) M caused a significant prolongation of atrio-His bundle conduction time (A-H interval) as well as His bundle-ventricular conduction time (H-V interval). Lignocaine above 10(-5) M caused a similar prolongation of H-V interval with a minimum change of A-H interval. The conduction time from His bundle stimulus to the left ventricle (St-LV) at a low frequency (1 Hz) was also prolonged by these drugs around 10(-4) M. 3. OPC-88117 above 3 x 10(-6) M prolonged the effective and functional refractory periods of His bundle (ERPHB, FRPHB) as well as the effective refractory period of left ventricular muscle (ERPVM) in a dose-dependent manner. ERPHB, FRPHB and ERPVM were shortened by low concentrations of lignocaine (3 x 10(-6)-10(-5) M), but were prolonged by high concentrations (3 x 10(-5)-10(-4) M). 4. Lignocaine (3 x 10(-6)-10(-4) M) induced an upward displacement of the His bundle refractory curve, indicating a greater intraventricular conduction delay for premature excitation. In experiments with OPC-88117, such an upward displacement was observed only at 10(-4) M. 5. These results suggest that the primary electrophysiological effect of OPC-88117 is a lengthening of ventricular refractoriness, and that at high concentrations it may also exert lignocaine-like inhibition of ventricular conduction.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553187      PMCID: PMC1854682          DOI: 10.1111/j.1476-5381.1989.tb16880.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Effect of lidocaine and quinidine on steady-state characteristics and recovery kinetics of (dV/dt)max in guinea pig ventricular myocardium.

Authors:  C M Chen; L S Gettes; B G Katzung
Journal:  Circ Res       Date:  1975-07       Impact factor: 17.367

2.  Effects of bepridil on ventricular depolarization and repolarization of rabbit isolated hearts with particular reference to its possible proarrhythmic properties.

Authors:  T Osaka; I Kodama; J Toyama; K Yamada
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

Review 3.  Ionic mechanisms in heart muscle in relation to the genesis and the pharmacological control of cardiac arrhythmias.

Authors:  O Hauswirth; B N Singh
Journal:  Pharmacol Rev       Date:  1978-03       Impact factor: 25.468

4.  Electrophysiological actions of lidocaine on canine ventricular muscle and Purkinje fibers.

Authors:  L D Davis; J V Temte
Journal:  Circ Res       Date:  1969-05       Impact factor: 17.367

Review 5.  A classification of antiarrhythmic actions reassessed after a decade of new drugs.

Authors:  E M Vaughan Williams
Journal:  J Clin Pharmacol       Date:  1984-04       Impact factor: 3.126

Review 6.  Antiarrhythmic drug action. Blockade of the inward sodium current.

Authors:  A O Grant; C F Starmer; H C Strauss
Journal:  Circ Res       Date:  1984-10       Impact factor: 17.367

Review 7.  Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs.

Authors:  L M Hondeghem; B G Katzung
Journal:  Annu Rev Pharmacol Toxicol       Date:  1984       Impact factor: 13.820

8.  The influence of pH on th electrophysiological effects of lidocaine in guinea pig ventricular myocardium.

Authors:  A O Grant; L J Strauss; A G Wallace; H C Strauss
Journal:  Circ Res       Date:  1980-10       Impact factor: 17.367

9.  Effect of lidocaine on the early inward transient current in sheep cardiac Purkinje fibers.

Authors:  F M Weld; J T Bigger
Journal:  Circ Res       Date:  1975-11       Impact factor: 17.367

10.  Electrophysiological effects of OPC-88117, a new antiarrhythmic agent on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts.

Authors:  J Toyama; I Kodama; H Honjo; K Kamiya
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.